B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ATP1B2

MOLECULAR TARGET

ATPase Na+/K+ transporting subunit beta 2

UniProt: P14415NCBI Gene: 4824 compounds

ATP1B2 (ATPase Na+/K+ transporting subunit beta 2) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ATP1B2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide.2.087
2Digoxin1.956
3Ouabain1.393
4Digitoxin1.102

About ATP1B2 as a Drug Target

ATP1B2 (ATPase Na+/K+ transporting subunit beta 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented ATP1B2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ATP1B2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.